Skip to main content

UMB, International Consortium to Begin Ebola Vaccine Trials

By August 29, 2014News
umd-founding-campus

umd-founding-campus

A candidate Ebola vaccine could be given to healthy volunteers in the United Kingdom, The Gambia, and Mali as early as September, as part of a series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.

Human trials of this candidate vaccine, being co-developed by the National Institutes of Health (NIH) and GlaxoSmithKline (GSK), are to be accelerated with funding from an international consortium in response to the Ebola epidemic, which the World Health Organization (WHO) recently declared a public health emergency of international concern.

{iframe}http://www.oea.umaryland.edu/communications/news/?ViewStatus=FullArticle&articleDetail=23186{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.